OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 135 filers reported holding OCULAR THERAPEUTIX INC in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,102 | -38.5% | 15,319 | +1.0% | 0.00% | – |
Q2 2023 | $78,257 | +3.1% | 15,166 | +5.3% | 0.00% | – |
Q1 2023 | $75,930 | +65.9% | 14,408 | -11.5% | 0.00% | – |
Q4 2022 | $45,758 | -26.2% | 16,284 | +8.7% | 0.00% | – |
Q3 2022 | $62,000 | +5.1% | 14,986 | +2.4% | 0.00% | – |
Q2 2022 | $59,000 | -46.8% | 14,633 | -34.4% | 0.00% | – |
Q1 2022 | $111,000 | -42.2% | 22,316 | -18.9% | 0.00% | – |
Q4 2021 | $192,000 | -26.7% | 27,532 | +5.1% | 0.00% | -100.0% |
Q3 2021 | $262,000 | -45.0% | 26,185 | -22.1% | 0.00% | 0.0% |
Q2 2021 | $476,000 | -2.9% | 33,594 | +12.4% | 0.00% | -50.0% |
Q1 2021 | $490,000 | -9.8% | 29,885 | +14.0% | 0.00% | 0.0% |
Q4 2020 | $543,000 | +924.5% | 26,216 | +49.8% | 0.00% | – |
Q3 2019 | $53,000 | -26.4% | 17,500 | +7.5% | 0.00% | – |
Q2 2019 | $72,000 | +1.4% | 16,280 | -9.0% | 0.00% | – |
Q1 2019 | $71,000 | +2.9% | 17,889 | +2.5% | 0.00% | – |
Q4 2018 | $69,000 | -42.5% | 17,445 | +0.1% | 0.00% | -100.0% |
Q3 2016 | $120,000 | +17.6% | 17,423 | -15.5% | 0.00% | +100.0% |
Q2 2016 | $102,000 | -47.2% | 20,623 | +3.1% | 0.00% | -66.7% |
Q1 2016 | $193,000 | -6.8% | 20,009 | -9.4% | 0.00% | 0.0% |
Q4 2015 | $207,000 | – | 22,078 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |